|
|
||||||||
-Glutamylcysteine Synthetase Subunit Gene Expression in Retinal Müller Cells by Oxidative Stress
1 From the Division of Gastrointestinal and Liver Diseases, Department of Medicine, USC Liver Disease Research Center, University of Southern California School of Medicine, Los Angeles; and the 2 Department of Ophthalmology, Northwestern University Medical School, Chicago, Illinois.
| Abstract |
|---|
|
|
|---|
-glutamylcysteine synthetase (GCS) heavy and
light subunit gene expression in Müller cells under conditions of
oxidative stress. METHODS. Experiments were carried out with an SV40 transformed cell line (rMC-1) that exhibits the phenotype of rat retinal Müller cells. Endogenous glutathione levels were modified by treating cells with diethyl maleate (DEM), D,L-buthionine sulfoximine (BSO), or tert-butylhydroquinone (TBH). In other experiments, cells were grown in either high (28 mM) or normal (5.5 mM) glucose medium for 1 week to examine the effects of hyperglycemia. Cells were processed for reduced glutathione (GSH) measurement, RNA extraction, cell count, and, in some cases, lactate dehydrogenase activity. The steady state mRNA levels of GCS heavy and light subunits were measured by northern blot analysis using specific cDNA probes. Changes in mRNA levels were normalized to ß-actin or 18S rRNA.
RESULTS. Treatment with DEM for 30 minutes depleted cell GSH to 20% to 30% of the normal value. GSH content recovered completely 6 hours after returning to normal medium. BSO treatment for 12 hours followed by a medium change for 6 hours resulted in a cell GSH level that was 26% that of untreated cells. If cells were left in BSO for 18 hours, however, GSH levels were reduced to <1%. Treatment with TBH for 12 hours led to a 77% increase in cellular GSH level. Treatment with DEM, TBH, or BSO for 18 hours led to a significant induction of the mRNA level of the GCS subunits, regardless of glucose concentration in the medium. Shorter BSO treatment exerted no effect. Prolonged hyperglycemia resulted in 30% lower GSH level, 55% lower GCS heavy subunit, and 30% lower GCS light subunit mRNA levels.
CONCLUSIONS. Oxidative stress induced the gene expression of GCS heavy and light subunits in Müller cells. The effect of BSO on mRNA levels correlated with the degree of GSH depletion. Prolonged hyperglycemia lowered GCS subunit mRNA and GSH levels.
| Introduction |
|---|
|
|
|---|
There is good evidence that Müller cells, the major support cells in the retina, play an important role in regulating GSH levels in the retina.9 These cells are present in the retina of all vertebrate species and perform many of the functions carried out by astrocytes, oligodendrocytes, and ependymal cells in the central nervous system.9 Recent studies indicate that retinal Müller cells may actively participate in neuronal protection by providing GSH to neurons, although the mechanism underlying this process is poorly understood. Specifically, GSH has been shown to be predominantly confined to Müller cells, and a recent study suggests that GSH is transferred from Müller cells to neurons under ischemic conditions.10 Despite this important role, very little is known about the regulation of GSH biosynthesis in Müller cells.
A major determinant of GSH biosynthesis is the activity of the
rate-limiting enzyme
-glutamylcysteine synthetase
(GCS).11
12
GCS is composed of heavy (GCS-HS;
Mr ~73,000) and light (GCS-LS;
Mr ~30,000) subunits that are
encoded by different genes in rat and human genomes.13
14
15
16
The enzyme may be dissociated under nondenaturing conditions by
treatment with dithiothreitol.17
The heavy subunit
obtained after this treatment exhibits all the catalytic activity of
the isolated enzyme and feedback inhibition by GSH.17
The
light subunit is enzymatically inactive but plays an important
regulatory function by lowering the Km
of GCS for glutamate and raising the
Ki for GSH.14
18
Thus,
the holoenzyme is catalytically more efficient and less subject to
inhibition by GSH than the heavy subunit.
Regulation of GCS has been a subject of intense study in many cell types.19 20 21 22 23 24 25 26 27 28 29 30 31 32 However, very little is known about GCS gene regulation in neural cells. Transcriptional and posttranscriptional regulation of both subunits have been described. We and others have shown that the gene expression of both GCS subunits are upregulated under oxidative stress and treatment with diethyl maleate (DEM) and tert-butylhydroquinone (TBH).23 25 28 32 We have also shown that in hepatocytes, hormones such as insulin and glucocorticoids upregulated the expression of GCS-HS without affecting GCS-LS.25 29 In addition, during periods of rapid liver growth such as plating hepatocytes under low cell density and liver regeneration after partial hepatectomy, the gene expression of GCS-HS but not GCS-LS was upregulated.25 29 30 Thus, the two subunits of GCS appear to be differentially regulated. Recently, Urata and colleagues31 reported decreased GCS-HS gene expression in mouse endothelial cells after prolonged hyperglycemia. Whether the light subunit is similarly affected was not examined.
In the present study, we examined the effect of oxidative stress and prolonged hyperglycemia on the gene expression of the heavy and light subunits of GCS. These conditions were chosen because of the propensity of the Müller cells to be under oxidative stress and the role of hyperglycemia in diabetic retinopathy. These present studies represent the initial characterization of the regulation of the two GCS subunits in this cell type and the first study to examine the effect of prolonged hyperglycemia on the GCS light subunit.
| Materials and Methods |
|---|
|
|
|---|
Culture and Treatment of Müller Cells
These studies were carried out using an immortalized Müller
cell line that was previously characterized.33
Müller cell cultures were passaged in DMEM (28 mM glucose)
supplemented with FBS (10%), penicillin (100 U/ml), and streptomycin
(100 µg/ml) in a humidified atmosphere of 5%
CO2/95% air. Medium was changed every 2 to 3
days, and cells were grown to confluence using T-75 flasks. Cells at
passages 11 to 22 were used in the current studies.
To study the effects of DEM, BSO, and TBH, 10 x 106 Müller cells were plated per 100-mm x 15-mm Falcon Primaria culture dish (Becton Dickinson, Lincoln Park, NJ) using cells grown in DMEM containing 10% FBS and 28 mM or 5.5 mM glucose for at least 7 days. To examine the effect of DEM, cells were treated with 0.2 mM DEM or vehicle for 20 minutes, followed by a medium change to DMEM for 6 hours. To examine the effect of BSO, cells were treated with 1 mM BSO or vehicle for 12 hours followed by medium change to DMEM for an additional 6 hours or BSO continuously for 18 hours. To examine the effect of TBH, cells were treated with 50 µM TBH or vehicle for 12 hours. At the end of the treatment, cells were processed for GSH measurement by the recycling method of Tietze.34 RNA extraction and lactate dehydrogenase measurement were performed as described elsewhere.35 The dosage and treatment duration of these agents are based on our previous findings using cultured rat hepatocytes.25
To study the effects of prolonged exposure to a high glucose concentration, Müller cells were grown in DMEM containing 10% FBS and 5.5 mM glucose (normal glucose) or 28 mM glucose (high glucose) for 7 days. To determine the effects of glucose on cell growth, 1.8 x 106 cells were plated per 100-mm x 15-mm dish, and the number of cells and viability were determined daily using a hemocytometer. Viability was determined by 0.2% trypan blue exclusion as described previously.25 At the end of the seventh day, cells were processed for GSH determination, RNA extraction, and lactate dehydrogenase measurement.
Nucleic Acid Extraction
Poly(A)+RNA (mRNA) was isolated from
Müller cells according to the method provided by Invitrogen
(Carlsbad, CA) along with the messenger RNA isolation kit (Fast Track
2.0). RNA concentration was determined spectrophotometrically before
use.
Northern Hybridization Analysis
Northern hybridization analysis was performed on
poly(A)+RNA (3 µg) using standard procedures
as described previously.25
The GCS-HS cDNA probe is
comprised of a 390-bp fragment corresponding to nucleotides 79 to 468
of the published rat kidney GCS-HS sequence,13
and the
GCS-LS cDNA probe is comprised of a 1.1-kb fragment corresponding to
nucleotides 122 to 1232 of the published rat kidney GCS-LS
sequence.14
Both were labeled with
[32P]dCTP using a random-primer kit (Primer-It
II Kit; Stratagene, La Jolla, CA). To ensure equal loading of RNA
samples, the same membrane was rehybridized with
32P-labeled human ß-actin or 18S cDNA probes
(Clontech, Palo Alto, CA). Autoradiography and densitometry (Gel
Documentation System, Scientific Technologies, Carlsbad, CA and NIH
Image 1.60 software program) were used to quantitate relative RNA
content. In the case of GCS-LS in which multiple mRNA species exist,
all the bands were quantitated before being used for comparison.
Results of northern blot analysis were normalized to ß-actin or 18S
RNA levels.
Statistical Analysis
Mean values from duplicate plates were used for comparison, and
the mean values of multiple experiments were compared by paired
two-tailed Students t-test (two comparisons) or ANOVA
followed by Fishers test (multiple comparisons). For cell GSH levels,
actual values were compared. For changes in mRNA levels, ratios of
GCS-HS or GCS-LS to ß-actin or 18S densitometric values were
compared. The criterion for significance was P < 0.05.
Results are shown as mean ± SEM of n, the number of
experiments.
| Results |
|---|
|
|
|---|
|
Effects of DEM, BSO, TBH, and Glucose Concentration on GCS Subunit
Gene Expression
Next, we examined mRNA levels in Müller cells treated with
agents that altered GSH levels. Figure 1
shows that treatment of Müller cells with TBH and DEM led to a
significant increase in the steady state GCS-HS mRNA level. However,
with respect to BSO, the steady state mRNA level of GCS-HS increased
only after 18 hours of continuous treatment. The difference between the
two BSO treatments was in the magnitude of GSH depletion. Thus,
increased GCS-HS expression occurred only when the cell GSH level was
reduced to a very low level (<1%). However, no effect was seen when
cell GSH level was reduced to 26% of control. Moreover, these
treatments also induced comparable changes in the mRNA level of GCS-LS
(Fig. 2) .
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The major physiological and pathologic stress that the retina is
exposed to is oxidative stress, which is known to influence the
expression of several key enzymes involved in GSH metabolism and other
detoxifying enzymes. These enzymes include GSH-peroxidase,
GSSG-reductase,
-glutamyltranspeptidase, GCS, superoxide
dismutase, and catalase.40
Although it is known that the
Müller cells are the major support cells in the retina and that
they are one of the major sources of retinal GSH,9
10
no
information is available on the regulation of GSH biosynthesis in these
cells. The present study focused on one of the major determinants of
GSH biosynthesis, namely the expression of GCS, in Müller cells.
Treatment of Müller cells with agents known to induce oxidative stress such as TBH, DEM, and BSO also induced the expression of both subunits of GCS to a comparable extent. This is similar to the response of hepatocytes and occurred independent of glucose concentration in the medium. The effect of BSO is particularly noteworthy. No effect was observed until the cellular GSH level was profoundly depressed (<1%). Moreover, the effect of BSO was dependent on the magnitude of GSH depletion and was similar to that observed with hepatocytes, in which depletion to less than 10% was required to detect significant changes in GCS subunit expression.25 Whether this reflects the level of oxidative stress or the GSH level itself remains unclear and will require further study.
GCS subunits appear also to be under differential regulation. Gipp et al.16 found no correlation between the steady state mRNA levels of the two GCS subunits. We and others have shown that oxidative stress and DEM upregulated both GCS subunits in a variety of cell types.23 25 32 On the other hand, only the heavy subunit was upregulated by hormones such as insulin and glucocorticoids and during periods of rapid liver growth.25 29 30 Our results suggested that in liver cells, there may be more GCS light subunit than heavy subunit because modulation of the heavy subunit alone resulted in changes in cell GCS activity and GSH level.29 30 We have not examined the effect of insulin and glucocorticoid on GCS regulation in Müller cells.
Our data show that GCS subunit expression in Müller cells is significantly affected by the exogenous glucose concentration. After prolonged exposure to a high glucose concentration, the mRNA level of both the heavy and light subunits of GCS fell. Interestingly, the heavy subunit exhibited a more significant decrease than the light subunit (55% versus 30%). Under these conditions, the cell GSH only fell by 30%. This would suggest that in contrast to liver cells in which there may be more GCS light subunit than heavy subunit, these two subunits may be present in an equal amount in the Müller cell. Unfortunately, antibodies to the GCS-LS are not currently available; hence, the actual light chain levels could not be determined.
The effect of prolonged hyperglycemia on cell growth deserves brief mention. Under this condition, Müller cells exhibited faster rates of cell growth after the fourth day of plating, and the expression of GCS-HS and GCS-LS were lower. Mouse endothelial cells also exhibited a similar magnitude of fall in the expression of GCS-HS, but whether glucose concentration affected the growth was not mentioned.31 In contrast, we found that when hepatocytes are under periods of rapid growth, the expression of GCS-HS is induced while that of the GCS-LS is unchanged.29 30 Whether GCS expression is also induced during periods of rapid growth in other types of cells is unclear. Our speculation is that in the case of prolonged hyperglycemia, it is the glucose effect rather than a difference in cell growth that predominated in the overall GCS expression.
Although our findings on GCS expression in prolonged hyperglycemia may be of general interest with respect to diabetes, one must exercise caution in extrapolating these findings to diabetic retinopathy. The molecular mechanisms by which hyperglycemia induces retinopathy are still poorly understood. Diabetes is associated with increased production of free radicals and lipid peroxides in the retina.36 37 Increased oxidative stress and decreased antioxidant defense systems have been implicated.38 39 40 41 Some of the complications of diabetic retinopathy were prevented by treatment with antioxidants.39 One study reported no change in the retinal GCS activity.40 A plausible explanation for this observation is that the stimulatory effect of oxidative stress, which induces GCS, may be nullified by hyperglycemia, which has the opposite effect on GCS level. Thus, because oxidative stress is known to induce GCS, the lack of any change in GCS activity in the diabetic retina is probably due to hyperglycemia. Furthermore, our study suggests that this impaired response of GCS may also contribute to the decrease in retinal GSH observed in the diabetic retina.
In regard to the molecular mechanism(s) of oxidative stressinduced changes in GCS subunit expression, several studies have implicated AP-1 and ARE elements present in the 5'-flanking regions of the human GCS-HS and GCS-LS.24 26 32 42 The mechanism of glucose modulation of GCS remains unclear. Although prolonged hyperglycemia can induce oxidative stress via the formation of glycated products,41 oxidative stress is clearly not the mechanism. Additional work will be required to elucidate the molecular mechanism of glucose effect on GCS gene expression.
In summary, we have characterized, for the first time, the regulation of GCS subunit gene expression in Müller cells. Oxidative stress was found to induce the expression of both GCS subunits, a response similar to that of other cell types. Prolonged hyperglycemia, however, resulted in the decreased expression of both subunits and also decreased cell GSH levels. These studies constitute an important first step in our understanding of the role of Müller cells in GSH homeostasis in the retina.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by NIH Grants EY11135, EY03523, and DK-45334 and by unrestricted funds from Research to Prevent Blindness, Inc.
Submitted for publication November 9, 1998; revised March 8, 1999; accepted April 8, 1999.
Proprietary interest category: N.
| References |
|---|
|
|
|---|
-glutamylcysteine synthetase J Biol Chem 265,1588-1593
-glutamylcysteine synthetase J Biol Chem 268,20578-20583
-glutamylcysteine synthetase Biochem Biophys Res Commun 185,29-35[Medline][Order article via Infotrieve]
-glutamylcysteine synthetase and relative mRNA levels for heavy and light subunits in human normal tissues Biochem Biophys Res Commun 206,584-589[Medline][Order article via Infotrieve]
-glutamylcysteine synthetase into two subunits J Biol Chem 259,9345-9347
-glutamylcysteine synthetase J Biol Chem 268,19675-19680
-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells Mol Pharmacol 46,909-914[Abstract]
-glutamylcysteine synthetase by heavy metals in human leukemia cells J Biol Chem 271,14981-14988
-glutamylcysteine synthetase mRNA in rat kidney by methyl mercury Arch Biochem Biophys 296,350-353[Medline][Order article via Infotrieve]
-glutamylcysteine synthetase heavy subunit by oxidants in human alveolar epithelial cells Biochem Biophys Res Commun 229,832-837[Medline][Order article via Infotrieve]
-glutamylcysteine synthetase in rat lung epithelial L2 cells exposed to oxidative stress or glutathione depletion Arch Biochem Biophys 342,126-133[Medline][Order article via Infotrieve]
-glutamylcysteine synthetase J Biol Chem 272,30371-30379
-glutamylcysteine synthetase heavy and light subunit gene expression Biochem J 326,167-172
-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence J Biol Chem 272,7445-7454
-glutamylcysteine synthetase large subunit mRNA expression by butylated hydroxyanisole Toxicol Appl Pharmacol 126,150-155[Medline][Order article via Infotrieve]
-glutamylcysteine synthetase by diethyl maleate Radiat Res 147,592-297[Medline][Order article via Infotrieve]
-glutamylcysteine synthetase gene expression Mol Pharmacol 48,212-218[Abstract]
-glutamylcysteine synthetase by interleukin-1
and tumor necrosis factor-ß in mouse endothelial cells J Biol Chem 271,15146-15152
-glutamylcysteine synthetase: co-ordinate induction of the catalytic and regulatory subunits in HepG2 cells Biochem J 328,99-104
-glutamylcysteine synthetase regulatory subunit gene J Biol Chem 273,14683-14689This article has been cited by other articles:
![]() |
C. Livingstone and J. Davis Review: Targeting therapeutics against glutathione depletion in diabetes and its complications The British Journal of Diabetes & Vascular Disease, November 1, 2007; 7(6): 258 - 265. [Abstract] [PDF] |
||||
![]() |
N. Knoll, C. Ruhe, S. Veeriah, J. Sauer, M. Glei, E. P. Gallagher, and B. L. Pool-Zobel Genotoxicity of 4-Hydroxy-2-Nonenal in Human Colon Tumor Cells Is Associated with Cellular Levels of Glutathione and the Modulation of Glutathione S-Transferase A4 Expression by Butyrate Toxicol. Sci., July 1, 2005; 86(1): 27 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Robertson Chronic Oxidative Stress as a Central Mechanism for Glucose Toxicity in Pancreatic Islet Beta Cells in Diabetes J. Biol. Chem., October 8, 2004; 279(41): 42351 - 42354. [Full Text] [PDF] |
||||
![]() |
H. J. Gukasyan, R. Kannan, V. H. L. Lee, and K.-J. Kim Regulation of L-Cystine Transport and Intracellular GSH Level by a Nitric Oxide Donor in Primary Cultured Rabbit Conjunctival Epithelial Cell Layers Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1202 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tomi, K.-i. Hosoya, H. Takanaga, S. Ohtsuki, and T. Terasaki Induction of xCT Gene Expression and L-Cystine Transport Activity by Diethyl Maleate at the Inner Blood-Retinal Barrier Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 774 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kannan, B. Ouyang, E. Wawrousek, N. Kaplowitz, and U. P. Andley Regulation of GSH in {{alpha}}A-Expressing Human Lens Epithelial Cell Lines and in {{alpha}}A Knockout Mouse Lenses Invest. Ophthalmol. Vis. Sci., February 1, 2001; 42(2): 409 - 416. [Abstract] [Full Text] |
||||
![]() |
E. RunggerBrändle, A. A. Dosso, and P. M. Leuenberger Glial Reactivity, an Early Feature of Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1971 - 1980. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |